INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 387 filers reported holding INSMED INC in Q2 2024. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,937,301 | +381.5% | 551,303 | +95.0% | 3.24% | +451.6% |
| Q1 2024 | $7,671,442 | -61.7% | 282,766 | -56.2% | 0.59% | -63.6% |
| Q4 2023 | $20,021,306 | +23.2% | 646,057 | +0.4% | 1.61% | +4.3% |
| Q3 2023 | $16,250,597 | +19.3% | 643,588 | -0.3% | 1.54% | +44.6% |
| Q2 2023 | $13,623,975 | +6.4% | 645,686 | -14.0% | 1.07% | -7.4% |
| Q1 2023 | $12,802,555 | -14.4% | 750,883 | +0.3% | 1.15% | -17.0% |
| Q4 2022 | $14,964,421 | -8.2% | 748,970 | -1.0% | 1.39% | -15.8% |
| Q3 2022 | $16,293,000 | +8.4% | 756,417 | -0.8% | 1.65% | -5.7% |
| Q2 2022 | $15,030,000 | -13.3% | 762,182 | +3.3% | 1.75% | +14.4% |
| Q1 2022 | $17,338,000 | -8.9% | 737,794 | +5.6% | 1.53% | +12.3% |
| Q4 2021 | $19,024,000 | -43.7% | 698,369 | -43.1% | 1.36% | -38.8% |
| Q3 2021 | $33,799,000 | -14.3% | 1,227,283 | -11.4% | 2.23% | -5.9% |
| Q2 2021 | $39,436,000 | +21.8% | 1,385,648 | +45.7% | 2.37% | +10.1% |
| Q1 2021 | $32,389,000 | -9.2% | 950,953 | -11.2% | 2.15% | -18.6% |
| Q4 2020 | $35,661,000 | +8.2% | 1,071,219 | +4.5% | 2.64% | -21.9% |
| Q3 2020 | $32,954,000 | +16.8% | 1,025,341 | +0.1% | 3.38% | +2.7% |
| Q2 2020 | $28,213,000 | +72.6% | 1,024,438 | +0.5% | 3.29% | +17.8% |
| Q1 2020 | $16,346,000 | -47.1% | 1,019,737 | -21.2% | 2.79% | -29.3% |
| Q4 2019 | $30,890,000 | +35.3% | 1,293,548 | -0.1% | 3.95% | +14.3% |
| Q3 2019 | $22,839,000 | +913.3% | 1,294,743 | +627.7% | 3.45% | +203.7% |
| Q1 2016 | $2,254,000 | -50.8% | 177,930 | -29.5% | 1.14% | -40.8% |
| Q4 2015 | $4,583,000 | -9.4% | 252,495 | -7.3% | 1.92% | -23.2% |
| Q3 2015 | $5,058,000 | -10.5% | 272,393 | +17.7% | 2.50% | -6.1% |
| Q2 2015 | $5,653,000 | +29.4% | 231,471 | +10.2% | 2.66% | +19.2% |
| Q1 2015 | $4,369,000 | – | 210,066 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 955,462 | $24,460,000 | 13.75% |
| Foresite Capital Management IV, LLC | 1,561,185 | $39,966,000 | 11.30% |
| Asymmetry Capital Management, L.P. | 730,440 | $18,699,000 | 10.13% |
| NEXTHERA CAPITAL LP | 470,741 | $12,051,000 | 10.04% |
| Palo Alto Investors LP | 7,890,917 | $202,007,000 | 9.82% |
| Vivo Capital, LLC | 1,748,174 | $44,753,000 | 4.19% |
| ACUTA CAPITAL PARTNERS, LLC | 435,500 | $11,149,000 | 3.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $9,111,000 | 3.38% |
| Consonance Capital Management LP | 1,711,150 | $43,805,000 | 3.10% |
| Opus Point Partners Management, LLC | 26,936 | $690,000 | 1.02% |